Skip to content

argenx vs Genmab

argenx logo

argenx

United in our commitment to improve the lives of patients

2363 employees · est. 2008 · Boston, United States

VS
Genmab logo

Genmab

Differentiated human antibody therapeutics for the treatment of cancer

3102 employees · est. 1999 · Denmark

Genmab is the older company (2008 vs 1999).

Side-by-Side Comparison

argenx Genmab
Founded
2008 1999 older
Headquarters
Boston, United States Denmark
Employees
2363 3102
Industry
Biotechnology, Health and Wellness, Pharmaceutical Biotechnology, Pharmaceutical
Funding Stage
IPO IPO
Total Funding
$3.55B $2.28B
Funding Rounds
13 6
Services
Research and Development, Product Pipeline Development, Partnership in Antibody Innovation Development of Antibody Therapeutics, Pipeline of Medicines, Biotech Research
Target Customers
Patients with Autoimmune Diseases, Healthcare Professionals, Academic Collaborators Healthcare Professionals, Patients & Care Partners, Investors, Corporate Partners
Taxonomy
ImmunologyAutoimmune DiseasesAntibody-based MedicinesImmunotherapyMyasthenia GravisPemphigus Vulgaris +9 Antibody TherapeuticsCancer TreatmentBispecific AntibodiesAntibody-Drug ConjugatesImmune-Modulating AntibodiesClinical Pipeline +7
Website
argenx.com genmab.com
argenx logo

About argenx

argenx, a prominent name in the Biotechnology and Health and Wellness industries, is firmly positioned as a global leader in immunology. Established in 2008, the company is headquartered in the United States and is driven by its slogan, United in our commitment to improve the lives of patients. Spe...

Genmab logo

About Genmab

Genmab, founded in 1999, is a pioneering international biotechnology company headquartered in Denmark. Renowned for its expertise in antibody innovation, Genmab focuses on developing differentiated human antibody therapeutics aimed at treating cancer and other serious diseases. Through its innovativ...

Also comparing in this category

Comparing more than these two?

Get argenx, Genmab and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does argenx compare?

A PDF of argenx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

argenx was founded in 2008, based in Boston, United States, with 2,363 employees. argenx, a prominent name in the Biotechnology and Health and Wellness industries, is firmly positioned as a global leader in immunology. Established in 2008, the company is headquartered in the United. Genmab was founded in 1999, based in Denmark, with 3,102 employees. Genmab, founded in 1999, is a pioneering international biotechnology company headquartered in Denmark. Renowned for its expertise in antibody innovation, Genmab focuses on developing differentiated hu.
argenx has raised $3.55B and Genmab $2.28B. Latest stage: argenx IPO, Genmab IPO.
Both work in Biotechnology and Pharmaceutical.

Compare argenx with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at argenx on 15 Jun 2026, and Genmab on 25 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout